NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1316202666 MD
Verify on CMS → Su Ah Bae, MD
Endocrinology, Diabetes & Metabolism Physician in Topeka, Kansas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,078 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
449
Medicare Part D claims · 136 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
52%
generic claims · 36% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Su Ah Bae, MD filed 449 Medicare Part D claims in 2024 as an Endocrinology, Diabetes & Metabolism Physician in Topeka, Kansas, prescribing 52% generic.
- 449
- Part D claims, 2024
- 52%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Su Ah Bae, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1316202666), first enumerated 07/11/2012.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 449 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1316202666 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1316202666
- ENUM-MID 2012
- TAX-MID 8K Endocrinology, Diabetes
- RX-LIGHT 449
- BOOK-THIN 48 in Kansas
- PHOTO-ENUM Maura Bucciarelli, D… · 2012
Su Ah Bae, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
449 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Su Ah Bae, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Su Ah Bae, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
449 84% vs specialty avg
Specialty distribution in Kansas
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Kansas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1316202666 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/11/2012 |
Hospital and facility affiliations
Facilities where Su Ah Bae, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Kaiser Foundation Health Plan OF Washington
Lynnwood, WA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Above average
Su Ah Bae, MD - brand share 36.0%
Endocrinology, Diabetes & Metabolism Physician average
36% brand-name claims vs 52% generic, on 449 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
449
Total Claims
$116K
Total Drug Cost
136
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 895.7
- Total Day Supply
- 26,231
- Brand vs Generic
- 36% brand / 52% generic
- Brand Drug Cost
- $110K
- Generic Drug Cost
- $4K
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.54
- Gender Split
- 71% female / 29% male
- Age Distribution
- <65: 14, 65-74: 65, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Su Ah Bae, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Levothyroxine Sodium
Levothyroxine Sodium
81 claims
- Methimazole
Methimazole
52 claims
- Nano 2nd Gen Pen N…
Nano 2nd Gen Pen Needle
33 claims
- Glipizide 21
Glipizide
21 claims
- Jardiance 17
Jardiance
17 claims
- Soliqua 100-33 16
Soliqua 100-33
16 claims
- Alendronate Sodium 14
Alendronate Sodium
14 claims
- Forteo 13
Forteo
13 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 81 |
| Methimazole | 52 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 33 |
| Glipizide | 21 |
| Jardiance Empagliflozin | 17 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 16 |
| Alendronate Sodium | 14 |
| Forteo Teriparatide | 13 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 12 |
| Tresiba Flextouch U-200 Insulin Degludec | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in KS →
All providers in Kansas →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Su Ah Bae, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
8,078
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,739
Avg Claims per Provider
Su Ah Bae, MD's 449 claims are below the specialty average of 2,739.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Bae, both outside Kansas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2012)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as Bae.
One of 48 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Kansas, 5 are shown here.
Dr. Mini Abraham
M.D.
Overland Park, KS
Dr. Bahaa Abu Bakr
MD
Topeka, KS
Dr. Noor Addasi
M.D.
Topeka, KS
Dr. Abeer Anabtawi
MD
Kansas City, KS
Dr. Dana Awad
MD
Topeka, KS
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Su Ah Bae, MD's specialty? ▼
Su Ah Bae, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Topeka, Kansas. Credentials: MD.
How much does Su Ah Bae, MD prescribe under Medicare Part D? ▼
In 2024, Su Ah Bae, MD wrote 449 Medicare Part D claims totaling $116K in drug costs for 136 beneficiaries.
Where is Su Ah Bae, MD located? ▼
Su Ah Bae, MD is located at 3520 SW 6TH AVE, Topeka, KS, 66606. Phone: (785) 368-0445.
What is Su Ah Bae, MD's NPI number? ▼
Su Ah Bae, MD's National Provider Identifier (NPI) is 1316202666, issued on 07/11/2012.
Does Su Ah Bae, MD prescribe more brand-name or generic drugs? ▼
Su Ah Bae, MD's prescribing is 36% brand-name and 52% generic drugs by claim count, with $110K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 8,078 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,739 Medicare Part D claims per year.
What drugs does Su Ah Bae, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Su Ah Bae, MD's most frequently prescribed drugs include Levothyroxine Sodium, Methimazole, Nano 2nd Gen Pen Needle. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Su Ah Bae, MD accept Medicare? ▼
Su Ah Bae, MD appears in CMS Medicare data with 449 Part D claims and 136 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Su Ah Bae, MD's credentials? ▼
Su Ah Bae, MD's NPI is 1316202666 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.